Bronze plans have highest drug cost-sharing increase.
There’s been a significant increase in drug copayments and co-insurance fees for Affordable Care Act (ACA) health plans as compared to pre-reform health plans in the 2013 individual market, according to a recent study.
Drug Coverage & the Affordable Care Act from HealthPocket, examined new health plans from 46 states. The study showed that out-of-pocket costs for drugs increased an average of 34% as compared to the pre-ACA individual insurance market.
The four health plan metal tiers each had drug cost-sharing increases. Bronze health insurance plans had the highest increase at 58%, while Platinum health insurance plans had the lowest increase at 15%.
“Higher out-of-pocket costs can negatively affect medication adherence as well as increase patient inquiries about lower cost drugs within the same therapeutic class,” says Kev Coleman, head of research and data at HealthPocket, a consumer health-plan comparison website. “Poor drug adherence can lead to negative health outcomes and potentially higher healthcare costs in some situations. Increased patient inquiries about less-expensive drugs can decrease the number of patients a doctor can see in a given period of time.”
Plan enrollees using brand-name and specialty drugs face the greatest burden from the increases in copayments and coinsurance fees, according to the study. Those enrollees who use medications infrequently, on the contrary, are not likely to notice the cost-sharing increases.
The 34% increase in copayments and coinsurance fees does not mean that consumers will spend 34% more on drugs. Drug spending is also affected by multiple factors including deductible amounts, out-of-pocket caps and formulary.
“The short answer is that out-of-pocket costs for medications are increasing for those people who were previously insured in the individual market and have purchased a new plan compliant with the ACA,” Coleman adds.
Nearly one-out-of-five health insurance plans purchased privately by individuals and families lacked prescription drug coverage prior to the ACA.
In comparison, all new health plans in the individual market include a drug benefit. Additionally, some over-the-counter drugs such as aspirin, folic acid and iron supplements can be obtained without any out-of-pocket cost when used as preventive medicine.
Health plans in the individual insurance market should examine how drug cost-sharing increases affect drug adherence among enrollees and related clinical outcomes, according to Coleman.
“Additionally, health plans should examine prescribing habits of in-network healthcare providers to make certain that in cases of similar clinical effectiveness, the lowest cost on-formulary drug is being prescribed,” he says.
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 26th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More